Hopp til hovedinnhold

HTLV-1 nevrologiske komplikasjoner

Sist oppdatert: Sist revidert:
Sist revidert av:
  • Fredrik Romi, spesialist i nevrologi, dr med
  1. Cooper SA, van der Loeff MS, Taylor GP. The neurology of HTLV-1 infection. Pract Neurol 2009; 9: 16-26. PMID: 19151234 PubMed  
  2. Cruickshank JK, Rudge P, Dalgleish AG, Newton M, McLean BN, Barnard RO, Kendall BE, Miller DH. Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom. Brain 1989; 112: 1057-90. PMID:2775992 PubMed  
  3. King-Robson J, Hampton T, Rosadas C, Taylor GP, Stanton B. HTLV-1 encephalitis. Pract Neurol. 2021 Aug 30:practneurol-2021-003053. doi: 10.1136/practneurol-2021-003053. Epub ahead of print. PMID: 34462338. PubMed  
  4. Crawshaw AA, Dhasmana D, Jones B, Gabriel CM, Sturman S, Davies NWS, Taylor GP. Human T-cell lymphotropic virus (HTLV)-associated encephalopathy: an under-recognised cause of acute encephalitis? Case series and literature review. J Neurol. 2018 Apr;265(4):871-879. PMID: 29423617 PubMed  
  5. Khan MY, Khan IN, Farman M, Al Karim S, Qadri I, Kamal MA, Al Ghamdi K, Harakeh S. HTLV-1 Associated Neurological Disorders. Curr Top Med Chem. 2017;17(12):1320-1330 . pmid:28017149 PubMed  
  6. Araujo A, Bangham CRM, Casseb J, Gotuzzo E, Jacobson S, Martin F, Penalva de Oliveira A, Puccioni-Sohler M, Taylor GP, Yamano Y. Management of HAM/TSP: Systematic Review and Consensus-based Recommendations 2019. Neurol Clin Pract. 2021 Feb;11(1):49-56. doi: 10.1212/CPJ.0000000000000832. PMID: 33968472 PubMed  
  7. Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y, Yamano Y. Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy. N Engl J Med. 2018 Feb 8;378(6):529-538. PMID: 29414279 PubMed  
  • Unn Ljøstad, spesialist i nevrologi, professor PhD
  • Åse Mygland, spesialist i nevrologi, professor dr med